Research Blog

Caucus explores crucial role of NIH research funding

James Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, and Anthony Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), recently participated in a U.S. Senate National Institutes of Health (NIH) caucus briefing held in Washington, D.C., by Senate NIH caucus co-chairs Sens. Lindsey Graham (R-SC) and Dick Durbin (D-IL).

Vanderbilt researcher speaks to White House on ending segregation for people with intellectual disabilities

Erik Carter spoke about ending segregation in education and beyond during an invited presentation at a gathering of the President’s Committee for People with Intellectual Disabilities.

Next Steps at Vanderbilt takes huge leap forward thanks to federal grant

Tennessee’s first postsecondary education program for students with intellectual disabilities, Next Steps at Vanderbilt, will expand significantly thanks to new federal funding.

New awards honor contributions to translational research at VUMC

Two physician-scientist leaders at Vanderbilt University Medical Center were honored last week with newly created awards for helping to build and nurture Vanderbilt’s vibrant culture of clinical and translational research.

research default banner

Initiative speeds clinical trials contract negotiations

An initiative promoted by the Vanderbilt Institute of Clinical and Translational Research (VICTR) offers an opportunity to reduce by more than half the time it takes to negotiate clinical trial contracts.

Chazin honored with international biophysics award

Walter Chazin, Ph.D., director of the Vanderbilt Center for Structural Biology, is a recipient of a 2016 Fellow of the Biophysical Society award.

1 5 6 7 8 9 17